Anemia, a condition characterized by a decrease in the number of red blood cells or less than the normal quantity of hemoglobin in the blood, can be a diagnostic challenge due to its multifactorial etiologies. This guide aims to provide a comprehensive approach to the diagnosis of anemia.
The first step in the diagnostic process is a thorough patient history and physical examination. Key factors to consider include symptoms, duration, triggers, and family history. It's crucial to assess dietary habits, medications, and any history of bleeding. Physical examination may reveal pallor, jaundice, or signs of specific causes like splenomegaly.
Initial laboratory tests should include a complete blood count (CBC) and reticulocyte count. A low hemoglobin level confirms anemia, while the reticiculocyte count helps determine if the anemia is regenerative or non-regenerative. Further tests may include iron studies, vitamin B12, folate levels, and a peripheral blood smear.
Anemia can be classified based on the mean corpuscular volume (MCV) into microcytic, normocytic, and macrocytic types. Microcytic anemia is usually due to iron deficiency or thalassemia. Normocytic anemia can be caused by chronic disease, acute blood loss, or bone marrow failure. Macrocytic anemia is often due to vitamin B12 or folate deficiency.
When initial investigations do not yield a clear diagnosis, more advanced procedures may be required. Bone marrow biopsy can be helpful in evaluating unexplained normocytic anemia or suspected bone marrow disorders. Endoscopy or colonoscopy may be needed to identify sources of occult bleeding.
Anemia presents a diagnostic challenge due to its diverse causes. A systematic approach involving a thorough history, physical examination, appropriate laboratory tests, and classification based on MCV can streamline the diagnostic process. In complex cases, advanced procedures may be necessary to identify the underlying cause.
1.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
2.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
3.
Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.
4.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
5.
The FDA Approves the New Frontline Aggressive ALL Regimen.
1.
Hematopoietic Stem Cell Exhaustion in Blood Disorders
2.
Lymphomatoid Papulosis: What You Need to Know
3.
The Growing Crisis of Aplastic Anemia: A Call for Action
4.
Importance of Early Detection in Hematology
5.
Clonal Hematopoiesis Dynamics and Future Hematologic Outcomes
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
5.
Lung Cancer: Risk Factors and Prevention
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation